These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33362860)

  • 21. In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma.
    Wang X; Zheng K; Hao Z
    Front Oncol; 2024; 14():1338634. PubMed ID: 38333684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the Long Non-Coding RNA Profile of Undifferentiated Large Cell Lung Carcinoma.
    Shukla S
    Noncoding RNA; 2018 Feb; 4(1):. PubMed ID: 29657301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of a
    Stewart GL; Sage AP; Enfield KSS; Marshall EA; Cohn DE; Lam WL
    Front Genet; 2020; 11():615378. PubMed ID: 33505435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
    Li L; Liu YD; Zhan YT; Zhu YH; Li Y; Xie D; Guan XY
    Thorac Cancer; 2018 Jul; 9(7):775-784. PubMed ID: 29722145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
    Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W
    Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients.
    Wang W; Liu H; Li G
    Front Endocrinol (Lausanne); 2022; 13():947443. PubMed ID: 36105402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the prognostic and therapeutic values of cyclin E1 (
    Ullah MA; Farzana M; Islam MS; Moni R; Zohora US; Rahman MS
    Heliyon; 2022 Sep; 8(9):e10367. PubMed ID: 36091953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma.
    Wang L; Sparks-Wallace A; Casteel JL; Howell MEA; Ning S
    Front Oncol; 2021; 11():632638. PubMed ID: 33869018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling.
    Anusewicz D; Orzechowska M; Bednarek AK
    Sci Rep; 2020 Dec; 10(1):21128. PubMed ID: 33273537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F; Zhang L; Ren Y; Ma Q
    J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis.
    He C; Huang D; Yang F; Huang D; Cao Y; Peng J; Luo X
    Cancer Manag Res; 2022; 14():503-514. PubMed ID: 35173484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
    Li X; Li B; Ran P; Wang L
    Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
    Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
    Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study.
    Alabiad MA; Harb OA; Abozaid M; Embaby A; Mandour D; Hemeda R; Shalaby AM
    Iran J Pathol; 2021; 16(2):162-173. PubMed ID: 33936227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
    Wu X; Ruan L; Yang Y; Mei Q
    Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.